View Older Stories

Feb 23, 2026 08:43AM Piper Sandler on Biohaven Pharma (BHVN): 'We like the risk/reward at current levels'

Feb 5, 2026 04:21PM Goldman Sachs Starts Biohaven Pharma (BHVN) at Buy

Jan 21, 2026 05:04AM RBC Capital Upgrades Biohaven Pharma (BHVN) to Outperform

Jan 12, 2026 01:44PM Bairdon Biohaven (BHVN): 'e think case studies from today's presentation answers the major question lingering for BHV-1400'

Jan 12, 2026 11:20AM Biohaven reports early patient data from protein degrader programs

Dec 26, 2025 08:18AM Stifel Reiterates Xenon Pharmaceuticals (XENE) at Buy following Biohaven's failure

Dec 26, 2025 06:40AM H.C. Wainwright Reiterates Neutral Rating on Biohaven Pharmaceutical Holding (BHVN)

Dec 26, 2025 06:08AM Biohaven Pharma (BHVN) call put ratio 1 call to 1 put as share price lower before the bell

Dec 11, 2025 07:02AM Biohaven shares cancer drug trial results at European oncology meeting

Dec 3, 2025 06:07AM H.C. Wainwright Downgrades Biohaven Pharmaceutical Holding (BHVN) to Neutral

Nov 26, 2025 04:18AM UBS Downgrades Biohaven Pharmaceutical Holding (BHVN) to Neutral

Nov 17, 2025 07:38AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $26 at Morgan Stanley

Nov 12, 2025 08:35AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $14 at Citi

Nov 11, 2025 04:29AM William Blair Reiterates Market Perform Rating on Biohaven Pharmaceutical Holding (BHVN)

Nov 10, 2025 07:40AM Biohaven Pharma (BHVN) Tops Q3 EPS by 24c

Nov 6, 2025 08:37AM Piper Sandler Slashes Biohaven Pharmaceutical (BHVN) Stock PT as 'FDA Says No to Troriluzole'

Nov 6, 2025 02:23AM Bernstein SocGen Group Downgrades Biohaven Pharmaceutical Holding (BHVN) to Market Perform

Nov 5, 2025 04:09PM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $15 at Leerink Partners

Nov 5, 2025 03:33PM BofA Securities Downgrades Biohaven Pharmaceutical Holding (BHVN) to Neutral

Nov 5, 2025 10:51AM Raymond James Comments on Biohaven (BHVN) Post Management Call

Nov 5, 2025 10:00AM William Blair Downgrades Biohaven Pharmaceutical Holding (BHVN) to Market Perform

Nov 5, 2025 08:20AM JPMorgan on Biohaven Pharmaceutical (BHVN): 'expect the stock to be under some pressure'

Nov 5, 2025 08:19AM William Blair on Biohaven (BHVN): 'Expect Weakness'

Nov 5, 2025 08:17AM Morgan Stanley on Biohaven (BHVN): 'The next catalyst for the stock is Opakalim (BHV-7000; Kv7 activator) Ph2/3 data in major depressive disorder (MDD)'

Nov 5, 2025 08:16AM Raymond James on Biohaven Pharmaceutical Holding (BHVN): 'Meaningful Value Remains', 'Sticking with it'

Nov 5, 2025 06:10AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $42 at Baird

Nov 5, 2025 01:56AM FDA rejects Biohaven drug application for rare brain disorder

Nov 3, 2025 10:00AM Truist: 'QURE Update Minimal Read-Through To PTCT & WVE, In Our View'

Nov 3, 2025 09:24AM Raymond James on Biohaven (BHVN) Amid News Shock: 'QURE Sympathy Move Seems Misplaced'

Nov 3, 2025 07:38AM Biohaven Pharma (BHVN) Weakness May Be Tied to uniQure (QURE) Setback in Huntington's Disease

Sep 17, 2025 05:55AM Citi Starts Biohaven Pharmaceutical Holding (BHVN) at Buy

Sep 16, 2025 09:32AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $26 at UBS

Sep 10, 2025 09:16AM RBC Capital on Biotech: 'Who Wins and Who Loses If RFK, Jr. Goes'

Aug 30, 2025 04:00PM Why public perception matters so much for biotech valuations

Aug 25, 2025 05:05AM Increasing unusual put option volume: FIVN OPEN BHVN XLB XLI ONDS LQDA ROST

Aug 22, 2025 07:04AM Biohaven receives FDA update on troriluzole drug application

Aug 19, 2025 05:05AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $60 at BTIG

Aug 12, 2025 06:41AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $30 at H.C. Wainwright

Aug 12, 2025 04:58AM Increasing unusual put option volume: OPEN BHVN ATYR TAP SBET XLP ACN LITE MSOS DOCN SHW

Aug 11, 2025 07:48AM Biohaven Pharma (BHVN) Tops Q2 EPS by 31c

Jul 22, 2025 05:52PM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Jul 22, 2025 04:00PM BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biohaven Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Jul 22, 2025 01:31PM ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BHVN

Jul 20, 2025 03:35PM ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BHVN

Jul 20, 2025 10:50AM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Jul 19, 2025 03:30PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BHVN

Jul 18, 2025 06:00PM Kirby McInerney LLP Reminds Biohaven Ltd. (BHVN) Investors of Class Action Filing and Encourages Investors to Contact the Firm

Jul 18, 2025 03:17PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BHVN

Jul 16, 2025 04:00PM BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biohaven Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

May 30, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)

View Older Stories